Foley Attorneys Submitted Two Amicus Briefs to the Federal Circuit Related to ACLU v. Myriad
November 10, 2010
Foley attorneys filed two amicus briefs with the Federal Circuit in the AMP et al. v. USPTO et al. (ACLU v. Myriad), a much discussed case relating to gene patents. Foley attorneys submitted one brief on behalf of Rosetta Genomics and George Mason University. Different Foley attorneys also filed a different brief on behalf of Alnylam Pharmaceuticals. Both briefs conclude that isolated DNA composition claims are patent eligible under current law, and should continue to meet the threshold of 35 U.S.C. § 101 when applying scientific facts to the law.
Related News
May 22, 2025
Press Releases
Foley Continues Expansion in California with Two Corporate Partners in Silicon Valley
Foley & Lardner LLP announced today that it has expanded its Innovative Technology Sector and Transactions Practice Group with the addition of partners Gurpreet Bal and Shaalu Mehra to the firm’s Silicon Valley office. Both attorneys bring substantial experience advising technology companies, investors, and founders on complex transactional and corporate matters.
May 12, 2025
Press Releases
Foley Expands East Coast Litigation Bench, Adds Three Partners in New York and Raleigh
Foley & Lardner LLP announced today that it has strengthened its East Coast presence with the addition of three partners to its Litigation Department.
May 8, 2025
Press Releases
Foley Expands Technology and Energy Capabilities with Addition of Two Digital Infrastructure Partners
Foley & Lardner LLP announced today the addition of partners Daniel Farris and Joe McClendon to its Chicago office, further enhancing the firm’s Technology Transactions, Cybersecurity, and Privacy Practice and its Energy & Infrastructure and Innovative Technology Sectors.